Replies to post #249513 on Biotech Values

[Mufaso]

VKTX/MDGL - Both Madrigal and Viking Therapeutics are up significantly in the last month or so. It looks to me like the obesity drug/"triple G" induced across the board Nash shorting has come to an end and I expect that the short interest for both stocks plus and a number of other Nash stocks will decrease.

[DewDiligence]

NGM acquired_by PE group_for $1.55/sh cash—an 80% premium to the “unaffected” share price on 12/29/23:

https://finance.yahoo.com/news/ngm-bio-entered-definitive-agreement-140300578.html

The buyer is The Column Group, LP. The nominal deal value is $135M.

p.s. It's a coincidence that NGM, a paritcipant in the NASH arena, closed its going-private deal on the same day that there was market-moving NASH news from B-I / ZEAL.CO.